[Updated] UK SACT Board: Good Practice Guidance for Immuno-Oncology Medicines

UK SACT Board

 

Good Practice Guidance for Immuno-Oncology Medicines – May 2024

The UK SACT Board’s Good Practice Guidance for Immuno-Oncology Medicines has been updated.

This guideline is designed to give a practical framework for the safe introduction and ongoing use of immunotherapy in existing Systemic Anti-Cancer Therapy (SACT) services.

This guideline is available on the UK SACT Board publication page: https://www.uksactboard.org/publications

Latest News

By BOPA Committee on 23rd May 2024

CAPhO IDEA Virtual Workshop Inclusion, Diversity, Equity and Access (IDEA) in Oncology Pharmacy Virtual Workshop

BOPA and CAPhO ongoing collaboration CAPhO will be hosting a virtual half-day workshop on IDEA (Inclusion, Diversity, Equity and Accessibility) in Oncology Pharmacy on Saturday, June 1st from 9am-2:30pm MDT…

Read article
By BOPA committee on 22nd May 2024

Podcast released: Let’s Talk About Research

In this episode we are joined by Pinkie Chambers. We discuss her current research project, the role of a pharmacist as a principal investigator and getting involved in research. This…

Read article
By BOPA EDI Subcommittee on 22nd May 2024

Join BOPA’s Celebrate Pride Month Webinar on 6th June 2024

To celebrate Pride Month, BOPA is collaborating with European Cancer Organisation to host a webinar on clinical considerations for the safe and effective prescribing for trans individuals living with cancer.…

Read article
By BOPA SACT Verification Passport Group on 22nd May 2024

BOPA SACT Verification Passport Grandparenting Reminder

Dear member,   It has been 7 months since the launch of the BOPA SACT Verification Passport. We have over 100 registered sites and over 1000 users subscribed. This is…

Read article